The global pharmaceutical dissolution testing services market is anticipated to grow at a CAGR of 7.5% during the forecast period (2023-2030). Development of new facilities to meet the demand for dissolution services from pharmaceutical industry is a key factor driving the growth of the global pharmaceutical dissolution testing services market. For instance, in May 2023, Trinseo, a specialty material solutions provider, has announced the opening of its polycarbonate (PC) dissolution pilot facility in Terneuzen, the Netherlands. Further, in December 2021, Greater Manchester-based Seda Pharmaceutical Development Services (Seda) has acquired a new property and is on track to double its annual turnover to at least £7m in the next two years.
Browse the full report description of “Pharmaceutical Dissolution Testing Services Market Size, Share & Trends Analysis Report by Method (In-Vitro and In-Vivo), by Dosage Form (Capsules and Tablets), and by Dissolution Apparatus (Basket and Paddle) Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/pharmaceutical-dissolution-testing-services-market
Santander UK, which Seda has banked with since its inception in 2015, has provided it with a funding package of £2m which includes support for the acquisition of its new property in Cheadle, Stockport. Seda will undertake a full refit of the new property, with total investment nearing £4m, developing state-of-the-art laboratories and bespoke office space. This will enable it to invest in new equipment so it can expand the range of services it offers clients. Among the new facilities and equipment in plan are processing suites for oral solid dosage forms (tablets and capsules) and enhanced facilities for parenteral products (injections). A particular area of focus is building capabilities in nano formulation prototyping and characterization for the design and development of complex medicines such as lipid nanoparticles for mRNA delivery (as used in some COVID vaccines).
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Method
o By Dosage Form
o By Dissolution Apparatus
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including Intertek Group Plc., Avivia BV, Almac Group, Agilent Technologies, Inc., and Catalent, Inc. among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Pharmaceutical Dissolution Testing Services Market Report Segment
By Method
By Dosage Form
By Dissolution Apparatus
Global Pharmaceutical Dissolution Testing Services Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/pharmaceutical-dissolution-testing-services-market